KNB.L

Kanabo Group Plc
Kanabo Group PLC - Correction Director/PDMR Shareholding
31st October 2024, 09:48
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 4164K
Kanabo Group PLC
31 October 2024
 

The following amendment has been made to the Director/PDMR Dealings announcement released on 29 October 2024 at 11:29.

The correction relates Ian Mattioli direct and indirect interest in Ordinary Shares in the Company which should have been 18,011,111 Ordinary Shares representing approximately 2.85% of the total issued share capital*.

All other details remain unchanged.

The full amended text is shown below.

 

Kanabo Group Plc

("Kanabo" or the "Company")

Director/PDMR Dealing

Kanabo Group Plc (LSE:KNB) a  leading health tech company, announces that Ian Mattioli, Non-Executive Director and Chairperson, has transferred all of his 18,011,111 ordinary shares for nil consideration to his daughter, Laura Jade Mattioli, a closely associated person.

Following the transfer, Ian Mattioli, together with his closely associated persons beneficial interest, in the ordinary shares of the Company, is 18,011,111 representing 2.85% of the total issued share capital of the Company.

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES OR CONNECTED PERSONS

 

Enquiries:

 

Kanabo Group plc

Avihu Tamir, Chief Executive Officer

Assaf Vardimon, Chief Financial Officer

Ian Mattioli, Non-Executive Chair of the Board

 

+44 (0)20 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Eran Zucker / Lucy Williams / Charles Goodfellow

 

+44 (0)20 7469 0930

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 Ian Mattioli

 

2

 

Reason for the notification

 Purchase of shares

a)

 

Position/status

 

 

PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor

 

a)

 

Name

 

 

Kanabo Group Plc

b)

 

LEI

 

 

213800XPJFSNWJIYKN52

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2.5 pence each in Kanabo Group Plc



Identification code

GB00BYQCS703



b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




Nil Consideration

18,011,111 Ordinary Shares







d)

 

Aggregated information




- Aggregated volume

18,011,111



- Price

Nil Consideration



e)

 

Date of the transaction

 

 

28/10/2024

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFDESUFELSELS]]>
TwitterFacebookLinkedIn